Literature DB >> 33597894

Irisin: A New Code Uncover the Relationship of Skeletal Muscle and Cardiovascular Health During Exercise.

Chunlian Ma1, Haichao Ding2, Yuting Deng2, Hua Liu1, Xiaoling Xiong1, Yi Yang1.   

Abstract

Exercise not only produces beneficial effects on muscle itself via various molecular pathways, but also mediates the interaction between muscles and other organs in an autocrine/paracrine manner through myokines, which plays a positive role in maintaining overall health. Irisin, an exercise-derived myokine, has been found involved in the regulation of some cardiovascular diseases. However, the relationship between irisin and cardiovascular health is not fully elucidated and there are some divergences on the regulation of irisin by exercise. In this review, we present the current knowledge on the origin and physiology of irisin, describe the regulation of irisin by acute and chronic exercises, and discuss the divergences of the related research results. Importantly, we discuss the role of irisin as a biomarker in the diagnosis of cardiovascular diseases and describe its treatment and molecular mechanism in some cardiovascular diseases. It is expected that irisin will be used as a therapeutic agent to combat cardiovascular diseases or other disorders caused by inactivity in the near future.
Copyright © 2021 Ma, Ding, Deng, Liu, Xiong and Yang.

Entities:  

Keywords:  cardiovascular health; exercise; irisin; myokine; skeletal muscle

Year:  2021        PMID: 33597894      PMCID: PMC7882619          DOI: 10.3389/fphys.2021.620608

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  9 in total

1.  Irisin/FNDC5 influences myogenic markers on skeletal muscle following high and moderate-intensity exercise training in STZ-diabetic rats.

Authors:  Ehsan Arabzadeh; Hossein Shirvani; Masoumeh Ebadi Zahmatkesh; Shahin Riyahi Malayeri; Gholam Hossein Meftahi; Fatemeh Rostamkhani
Journal:  3 Biotech       Date:  2022-07-26       Impact factor: 2.893

Review 2.  Many Ways to Rome: Exercise, Cold Exposure and Diet-Do They All Affect BAT Activation and WAT Browning in the Same Manner?

Authors:  Anna K Scheel; Lena Espelage; Alexandra Chadt
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  Exercise Enhanced Cardiac Function in Mice With Radiation-Induced Heart Disease via the FNDC5/Irisin-Dependent Mitochondrial Turnover Pathway.

Authors:  Wuyang He; Yinghong Tang; Chunqiu Li; Xiaoyue Zhang; Shunping Huang; Benxu Tan; Zhenzhou Yang
Journal:  Front Physiol       Date:  2021-11-11       Impact factor: 4.566

4.  Irisin Is Correlated with Blood Pressure in Obstructive Sleep Apnea Patients.

Authors:  Xing Wang; Zhengjiao Zhang; Xiaoxin Lan; Keyou Fu; Guanhua Xu; Jingyi Zhao; Haibo Yuan
Journal:  Int J Hypertens       Date:  2021-11-11       Impact factor: 2.420

Review 5.  Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target.

Authors:  Chun-Liang Chen; Yu-Cheng Lin
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

6.  The effect of tai chi intervention on NLRP3 and its related antiviral inflammatory factors in the serum of patients with pre-diabetes.

Authors:  Shujuan Hu; Yingxing Hu; Peilin Long; Peixiong Li; Ping Chen; Xianwang Wang
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

Review 7.  Irisin, an Effective Treatment for Cardiovascular Diseases?

Authors:  Chen Liu; Aili Wei; Tianhui Wang
Journal:  J Cardiovasc Dev Dis       Date:  2022-09-13

Review 8.  Irisin at the crossroads of inter-organ communications: Challenge and implications.

Authors:  Renqing Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-04       Impact factor: 6.055

9.  Chronic Exercise Protects against the Progression of Renal Cyst Growth and Dysfunction in Rats with Polycystic Kidney Disease.

Authors:  Jiahe Qiu; Yoichi Sato; Lusi Xu; Takahiro Miura; Masahiro Kohzuki; Osamu Ito
Journal:  Med Sci Sports Exerc       Date:  2021-12-01       Impact factor: 5.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.